Search

Hutchison China MediTech Ltd ADR

Chiusa

SettoreSettore sanitario

12.4 1.47

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

11.58

Massimo

12.25

Metriche Chiave

By Trading Economics

Entrata

-8.9M

-8M

Vendite

3.7M

139M

P/E

Media del settore

121.8

57.366

Margine di Profitto

-5.724

Dipendenti

1,790

EBITDA

18M

4M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+18.52% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

205M

2.1B

Apertura precedente

10.93

Chiusura precedente

12.4

Notizie sul Sentiment di mercato

By Acuity

100%

0%

329 / 340 Classifica in Healthcare

Hutchison China MediTech Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

25 ago 2026, 23:18 UTC

News
Correlated Moves

The USD/ZAR is lower today, retreating after an early gain and tracking broader market sentiment amid a drop in crude oil prices.

25 ago 2026, 23:16 UTC

News
Correlated Moves

USD/SEK is lower in Tuesday's session, reflecting ongoing weakness near its one-month trading range. The decline aligns with broader trends in correlated pairs.

25 ago 2026, 23:16 UTC

News
Correlated Moves

RTX Corp has secured a $603 million contract for B-52 radar systems. Shares are trading higher in after-market hours following the announcement.

25 ago 2026, 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

25 ago 2026, 23:16 UTC

News

Ultragenyx Pharmaceutical granted nearly 46,000 restricted stock units to new hires, boosting shares in after-market trading amid ongoing strategic initiatives for rare diseases.

25 ago 2026, 23:16 UTC

News

Franklin Resources declared a quarterly dividend of $0.33 per share, contributing to positive sentiment as shares trade higher in after-market hours.

25 ago 2026, 23:12 UTC

News
Correlated Moves

Northrop Grumman received a $216 million contract modification for its Deep Space Advanced Radar Capability program, with shares trading higher in after-market hours.

25 ago 2026, 23:07 UTC

News

United States Oil Fund LP declined after hours amid rising crude inventories and geopolitical tensions in the Strait of Hormuz affecting oil supply dynamics.

25 ago 2026, 23:07 UTC

News

Concerns from Federal Reserve official Barkin about rising U.S. debt may be influencing sentiment. The Vanguard Mortgage-Backed Securities ETF traded roughly flat in after-market hours.

25 ago 2026, 23:06 UTC

Macro Event
News
Correlated Moves

The USD/HUF exchange rate is lower today, influenced by mixed U.S. economic data and unusual volatility in currency movements.

25 ago 2026, 23:06 UTC

News

Mondelez International will participate in the Barclays Global Consumer Staples Conference on September 9, 2026, as shares trade higher in after-market hours.

25 ago 2026, 23:06 UTC

News
Correlated Moves

Salesforce Inc shares declined during after-market hours, influenced by Intuit Inc's significant drop. The stock remains above its 20-day moving average despite the decline.

25 ago 2026, 23:06 UTC

News

Concerns about rising U.S. debt levels and China's stimulus outlook may be influencing investor sentiment, as BND remains roughly flat in after-market trading.

25 ago 2026, 23:06 UTC

News
Social Media

Wolfe Research upgraded Moderna to Peer Perform, citing positive melanoma trial results and estimating peak sales potential at $9.2 billion. Shares are higher in after-market hours.

25 ago 2026, 23:06 UTC

News

Kura Oncology Inc. reached a new 52-week high after CEO Troy Wilson acquired 100,000 shares for approximately $1.24 million, reflecting strong market sentiment.

25 ago 2026, 23:02 UTC

Event
News

Box Inc shares traded lower in after-market hours following second-quarter results that met expectations but lowered fiscal year 2027 adjusted EPS guidance to $1.54.

25 ago 2026, 23:02 UTC

Social Media
News

Intuit Inc. shares fell in after-hours trading following disappointing guidance, despite fourth-quarter results that exceeded expectations with adjusted EPS of $4.03.

25 ago 2026, 23:02 UTC

News

Walt Disney Co is implementing a voluntary early retirement program for executives amid ongoing restructuring efforts. Shares are lower in after-market trading.

25 ago 2026, 23:02 UTC

News

Kohl's Corp appointed Arianne Parisi as Chief Customer Officer to enhance customer engagement. Shares traded higher in after-market hours following the announcement.

25 ago 2026, 23:02 UTC

Event
News
Social Media

Zoom Communications reported strong Q2 results but issued third-quarter guidance below consensus. Shares declined in after-market trading following the lukewarm outlook.

25 ago 2026, 23:02 UTC

News

Market response to declining crude oil prices keeps USD/HKD trading roughly flat. Focus shifts to upcoming core PCE data and the Jackson Hole symposium.

25 ago 2026, 23:01 UTC

Event
News

nCino Inc's stock fell after its Q2 results showed EPS of $0.05, missing expectations, despite revenues of $161 million and raised full-year guidance.

25 ago 2026, 23:01 UTC

Social Media
Event
News

Semtech Corp reported Q2 net sales of $341.9 million, exceeding estimates. Shares are higher in after-market hours amid positive investor sentiment on growth prospects.

25 ago 2026, 23:01 UTC

News

Qfin Holdings Inc. shares declined in after-market trading following significant earnings misses and cautious guidance, despite earlier gains during the session.

25 ago 2026, 22:36 UTC

News

Par Pacific Holdings agreed to sell its 46% stake in Laramie Energy for $485 million, with shares trading higher in after-market hours.

25 ago 2026, 22:06 UTC

News

Electromed Inc reported record fourth-quarter results, but shares declined in after-market trading amid CEO retirement concerns. Net income rose to $11.3 million.

25 ago 2026, 21:02 UTC

News

Renasant Corp announced a leadership transition, naming Catherine Mealor as CFO starting January 1, 2027. Shares traded higher in after-market hours.

25 ago 2026, 21:02 UTC

News

TD Cowen raised the price target on Global Payments to $90.00 while maintaining a Hold rating. Shares advanced modestly in after-market trading.

25 ago 2026, 21:01 UTC

News

Asbury Automotive Group shares are lower in after-market hours following the termination of Chief Human Resources Officer Jed Milstein, effective August 19, 2026.

25 ago 2026, 20:09 UTC

News

OrthoPediatrics launched its 3P Pediatric Plating Platform Hip System for pediatric orthopedic surgeons. Shares are trading lower, continuing a recent trend of declines.

Confronto tra pari

Modifica del prezzo

Hutchison China MediTech Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

18.52% in crescita

Previsioni per 12 mesi

Media 14.53 USD  18.52%

Alto 16 USD

Basso 13.6 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hutchison China MediTech Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

1

Acquista

2

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat